description
Powered by Eupheria Biotech
Quality Level
product line
MISSION®
form
lyophilized powder
esiRNA cDNA target sequence
CCCCGTGAAGTCAAGAATTTCCACCTTTTCTCAAACAAAAAACCATTTCTTTGACACATTTGAATTAATAGCAGGACTTGCCCTTTGGGCCCATTCTTAGGTAAGATGAGGGTCTTTGAGCACAAGTACTATGAGATCTGTCAGTCAATCTAATAACCAGGCAGGTAATTAAGTGGCTCAAGAGCAAATAGGTTATTCAGTGCGGGTGTACCAGGCAGAGATGATTCATCTACCAAGTGGAACAGGAGAGGCCGGCTGTGATTTCATCGTGCTATTCAGAATGGGTACTATGTAAACTGTAAGGATTATTTATTTCAGGAACTTGTCACTCAGCATGTTTCAGATGACAGTTGACCACAGGTTACTAAAACTGTGGACAGCAAAACCTCAGAAAATGGGGAATTGAGCCTTGAAGAAGCAAAGCCACAGGTCCAGGATTCAAAATCCTCCCAATTCCCATGCCTGTGATTTAACTATAAAGTGTATGTGTGTGTGTGTAAAGCCGGGCCT
Ensembl | mouse accession no.
NCBI accession no.
shipped in
ambient
storage temp.
−20°C
Gene Information
mouse ... ERBB3(13867), Erbb3(13867)
General description
MISSION® esiRNA are endoribonuclease prepared siRNA. They are a heterogeneous mixture of siRNA that all target the same mRNA sequence. These multiple silencing triggers lead to highly-specific and effective gene silencing.
For additional details as well as to view all available esiRNA options, please visit SigmaAldrich.com/esiRNA.
For additional details as well as to view all available esiRNA options, please visit SigmaAldrich.com/esiRNA.
Legal Information
MISSION is a registered trademark of Merck KGaA, Darmstadt, Germany
存储类别
10 - Combustible liquids
flash_point_f
Not applicable
flash_point_c
Not applicable
法规信息
新产品
此项目有
C He et al.
Oncogene, 34(50), 6040-6054 (2015-03-24)
Mechanisms underlying ovarian cancer initiation and progression are unclear. Herein, we report that the Yes-associated protein (YAP), a major effector of the Hippo tumor suppressor pathway, interacts with ERBB signaling pathways to regulate the initiation and progression of ovarian cancer.
Maicol Mancini et al.
Science signaling, 8(379), ra53-ra53 (2015-06-04)
Despite initial responses to targeted kinase inhibitors, lung cancer patients presenting with primary epidermal growth factor receptor (EGFR) mutations acquire resistance, often due to a second-site mutation (T790M). However, clinical trials found no survival benefits in patients treated with a
全球贸易项目编号
| 货号 | GTIN |
|---|---|
| EMU154511-20UG | 04061828770571 |
| EMU154511-50UG | 04061828719426 |